KRM Ayurveda Limited Share Price & Stock Analysis

KRM Ayurveda Limited (NSE: KRMAYURVED) is a Delhi-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹521 Cr, it ranks #1,984 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 26 in Pharmaceutical Contract Manufacturing Services. The share price was ₹244.75 as of 16 Nov 2026.

Key Metrics

Current Price₹244.75
Market Cap₹521 Cr
NSE SymbolKRMAYURVED
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio25.9
Return on Equity17.54%
Return on Assets19.43%
Beta (1Y)0.97
HeadquartersDelhi
Websitewww.krmayurvedaindia.com

Latest Quarterly Results — Q1 FY27

Revenue₹32 Cr
Net Profit₹9 Cr
Net Margin28.1%
EPS (Basic)₹4.27
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Shareholding and Delivery

Promoters held 69.30% of KRM Ayurveda Limited's shares as of Sept 2026, against 69.15% in Mar 2026 (+0.15 percentage points).

About KRM Ayurveda Limited

KRM Ayurveda Limited operates a network of hospitals and clinics in India as well as abroad through telemedicine consulting and sales. The company provides treatment for kidney disorders, liver cirrhosis, diabetes, fatty liver, and arthritis. It also offers panchakarma therapies, abhyanga (oil massage), shirodhara, herbal steam baths, udvartana (herbal powder massage), chakra healing, orthopedic care, skin and hair care, women’s wellness, geriatric care, stress management, weight management, preventive health plans, and personalized nutrition and yoga consultation. In addition, it provides herbal medicines. The company was incorporated in 2019 and is based in Delhi, India.

Products and Services

1. Healthcare Facilities & Services-This segment operates a network of hospitals and clinics. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Healthcare Facilities & Services-100%

KRM Ayurveda Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of KRM Ayurveda Limited?

KRM Ayurveda Limited is trading at ₹244.75, with a market capitalisation of ₹521 Cr.

Which sector does KRM Ayurveda Limited belong to?

KRM Ayurveda Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of KRM Ayurveda Limited?

KRM Ayurveda Limited has a P/E of 25.9 and a return on equity of 17.54%.

What is the stock symbol of KRM Ayurveda Limited?

KRM Ayurveda Limited is listed on the NSE under the symbol KRMAYURVED.

What were KRM Ayurveda Limited's latest quarterly results?

In Q1 FY27, KRM Ayurveda Limited reported revenue of ₹32 Cr and net profit of ₹9 Cr, with basic EPS of ₹4.27 (standalone, parsed from the company's exchange filing).

What is the promoter holding in KRM Ayurveda Limited?

Promoters held 69.30% of KRM Ayurveda Limited's shares as of Sept 2026, against 69.15% in Mar 2026 (+0.15 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.